TAVOTEK BIOTHERAPEUTICS

tavotek-biotherapeutics-logo

Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Our company management and advisors consist of veteran pharmaceutical executives with multiple prior successes in the development of many blockbuster biologics currently in the market. Tavotek has 3 diverse R&D platform for biologics: TavoSelect (an innovative Phage Display Libra... ry), TavoPrecise (engineering platform for tissue-specific biologics), and TavoMIP (a multicyclic peptide platform). Along with these platforms, Tavotek has a rich and diverse pipeline of product candidates in various stages of development, focused on cancers, autoimmune conditions, and infectious diseases.

#SimilarOrganizations #People #Financial #Website #More

TAVOTEK BIOTHERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Health Care Life Science

Founded:
2019-01-01

Address:
Gwynedd, Pennsylvania, United States

Country:
United States

Website Url:
http://www.tavotek.com

Total Employee:
51+

Status:
Active

Contact:
267-405-9426

Email Addresses:
[email protected]

Total Funding:
55 M USD


Similar Organizations

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

not_available_image

Potrero Hill Therapeutics

Potrero Hill Therapeutics is a discovering and developing novel therapeutics through clinical proof of concept.

receptos-logo

Receptos

Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.

rnaimmune-logo

RNAimmune

RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.

rondo-therapeutics-logo

Rondo Therapeutics

Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.

sunshine-biopharma-logo

Sunshine Biopharma

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.

Current Employees Featured

mark-chiu_image

Mark Chiu
Mark Chiu President & Chief Scientific Officer @ Tavotek Biotherapeutics
President & Chief Scientific Officer

wei-zhang_image

Wei Zhang
Wei Zhang Chief Operation Officer @ Tavotek Biotherapeutics
Chief Operation Officer

mann-fung_image

Mann Fung
Mann Fung Chief Executive Officer @ Tavotek Biotherapeutics
Chief Executive Officer

Investors List

fontus-capital_image

Fontus Capital

Fontus Capital investment in Series B - Tavotek Biotherapeutics

cs-capital_image

CS Capital

CS Capital investment in Series B - Tavotek Biotherapeutics

gf-xinde-investment-management_image

GF Xinde Investment Management

GF Xinde Investment Management investment in Series A - Tavotek Biotherapeutics

cts-capital_image

CTS Capital

CTS Capital investment in Series A - Tavotek Biotherapeutics

ming-bioventures_image

Ming Bioventures

Ming Bioventures investment in Series A - Tavotek Biotherapeutics

lanhu-capital_image

Lanhu Capital

Lanhu Capital investment in Series A - Tavotek Biotherapeutics

bioventure_image

BioVenture

BioVenture investment in Series A - Tavotek Biotherapeutics

oriza-holdings_image

Oriza Holdings

Oriza Holdings investment in Series A - Tavotek Biotherapeutics

new-alliance-capital_image

New Alliance Capital

New Alliance Capital investment in Series A - Tavotek Biotherapeutics

apricot-capital-ceb8_image

Apricot Capital

Apricot Capital investment in Series A - Tavotek Biotherapeutics

Official Site Inspections

http://www.tavotek.com

  • Host name: 47.253.122.130
  • IP address: 47.253.122.130
  • Location: San Mateo United States
  • Latitude: 37.5517
  • Longitude: -122.33
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94402

Loading ...

More informations about "Tavotek Biotherapeutics"

Tavotek Biotherapeutics - Crunchbase Company Profile & Funding

Organization. Tavotek Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Tavotek Biotherapeutics focused on …See details»

TAVOTEK

Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with …See details»

Tavotek Biotherapeutics Co. Ltd. - Drug pipelines, Patents, Clinical ...

Mar 8, 2025 Tavotek is a biopharmaceutical corporation dedicated to identifying, acquiring, developing, and commercializing therapeutic drugs for patients with severe diseases that lack …See details»

Tavotek Biotherapeutics - Funding, Financials, Valuation & Investors

Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines. New. Resources. Advanced Search. ... How much funding has this …See details»

TAVOTEK

Before joining Tavotek, he was the Head of Digital Health and Information Technology at the Johnson and Johnson (J&J) Asia Pacific Innovation Center. While at J&J, he worked …See details»

TAVOTEK

(LOWER GWYNEDD, Pennsylvania, March 15, 2023) Tavotek Biotherapeutics, a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing medicines for unmet medical needs, was named a …See details»

Tavotek Biotherapeutics Company Profile | Management and

Tavotek Biotherapeutics Profile and History. Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing medicines for patients suffering from …See details»

Tavotek Biotherapeutics - VentureRadar

Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing medicines for patients suffering from debilitating diseases with significant …See details»

Tavotek Biotherapeutics | LinkedIn

Tavotek Biotherapeutics | 1,433 followers on LinkedIn. Innovative Therapies. Better Health. | Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and …See details»

Mann Fung - CEO at Tavotek Biotherapeutics | The Org

Dr. Mann Fung is the Chief Executive Officer of Tavotek Biotherapeutics. He has nearly 30 years of experience in the Regulatory, Pharmaceutical, and Finance Industries including FDA, Big …See details»

Tavotek Lab Inc Company Profile -Sales, Contacts, Competitors

Tavotek Lab Inc (trade name Tavotek Biotherapeutics) is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»

Tavotek专注于肿瘤与免疫疾病的新药研发 - 药时代DrugTimes

Dec 11, 2020 原文始发于微信公众号(药时代): Tavotek专注于肿瘤与免疫疾病的新药研发 【近日,美国生物科技主流媒体之一的BIOWORLD 期刊对Tavotek公司的首席执行官Dr. Mann …See details»

Tavotek Biotherapeutics Announces Completion of Round B …

Nov 19, 2021 Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing medicines for patients suffering from debilitating diseases …See details»

Tavotek Biotherapeutics on LinkedIn: #tavotek #biotechnology …

Tavotek Biotherapeutics is pioneering meaningful contributions to the field of biotherapeutics by providing relief and improving the quality of life for those affected by severe atopic dermatitis.See details»

TAVOTEK

Apr 7, 2022 Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing medicines for patients suffering from debilitating diseases …See details»

Tavotek Biotherapeutics Announces Completion of Round A1 and …

Mar 22, 2021 LOWER GWYNEDD, Pennsylvania, March 22, 2021 /PRNewswire/ -- Tavotek Biotherapeutics announces it has raised over $20M in Round A1 and Round A2 financing in …See details»

拓创生物多特异性抗体TAVO412获美国FDA批准临床试验医药新闻-…

⌈ByDrug医药新闻摘要⌋ 2022-11-07 11:27,触界生物:拓创生物(Tavotek)近日宣布,其自主研发的新型多特异性抗体TAVO412已获美国FDA批准开展临床试验,预计将于今年12月完成I期 …See details»

TAVOTEK

Oct 28, 2022 Tavotek has the opportunity to bring first-in-class multi-specific antibodies to cancer patients who have high unmet medical needs, which is the core driving force behind …See details»

Tavotek Announces a Research Agreement with Genmab for the …

May 25, 2020 Tavotek (US) is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating …See details»

拓创生物-拓创生物科技(苏州)有限公司-企业详情-InvestGO数据库-…

查看医药魔方InvestGO®数据库拓创生物的公司信息。拓创生物(拓创生物科技(苏州)有限公司),公司简介:Tavotek是一家专注于创新型大分子生物药物的早期研发、引进、临床开发和 …See details»

linkstock.net © 2022. All rights reserved